The Silent Epidemic: Sleep Disorder Market Set to Soar Beyond $88 Billion by 2034 Amidst Innovation Boom
Revolutionizing Rest: Yangtze River Pharma Unveils Groundbreaking Anti-Insomnia Drug, Fazamorexant, at World Sleep Congress